Your session is about to expire
← Back to Search
SBIRT for Gambing for Gambling Addiction
N/A
Waitlist Available
Research Sponsored by University of Maryland, College Park
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one month
Awards & highlights
Study Summary
This trial will study whether a problem gambling intervention can help reduce gambling behaviors in patients receiving medical care.
Eligible Conditions
- Gambling Addiction
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
gambling time back follow-up
Trial Design
2Treatment groups
Experimental Treatment
Group I: SBIRTExperimental Treatment1 Intervention
SBIRT intervention for Gambling
Group II: ControlExperimental Treatment1 Intervention
Participants randomized to the enhanced control condition will receive a handout with gambling resources.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SBIRT for Gambing
2023
N/A
~90
Find a Location
Who is running the clinical trial?
University of Maryland, College ParkLead Sponsor
154 Previous Clinical Trials
45,404 Total Patients Enrolled
University of Maryland, BaltimoreLead Sponsor
685 Previous Clinical Trials
373,015 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: SBIRT
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger